CHNC China Infrastructure Construct

CHNC Endeavors in Artificial Intelligence Systems for Its Educational Content

CHNC Endeavors in Artificial Intelligence Systems for Its Educational Content

HOUSTON, TX, Oct. 18, 2021 (GLOBE NEWSWIRE) -- via – Through artificial intelligence technology and various platform alliances around the globe, in approximately 30 to 45 days China Infrastructure Construction Corp. (OTC: CHNC) (dba Cannabis Bioscience International Holdings) will be able to distribute our educational products in the following additional languages: Mandarin, Cornish, Czech, Dutch, French, German, Greek, Hebrew, Hindi, Japanese, Kazakh, Korean, Polish, Russian, Tagalog, and Vietnamese.

Entering newer and emerging markets such as Russia, China or Japan is a landmark in our journey and a milestone in our industry. All of this will be possible with the implementation of artificial intelligence to our arsenal, allowing us to explore new ways of reaching a broader global audience.  “It will grant us the opportunity to develop our content alongside subtitles and audios in other languages the same way Netflix seamlessly does. The sky is the limit in what we can achieve with artificial intelligence,” says Anne Graham, Attorney at Law, CHNC’s Director of International Markets.

Furthermore, with this innovative technology, our content will break down the language barriers in many regions and will now have access to potential paying customers in 150 countries.

Moreover, with the new added platforms that will join the list of our worldwide alliances such as Unihance in Jordan, Alugha in Germany, Pocketmagazines, Zinio, Smashwords, Findawayvoices and Publishdrive, CHNC will now have exposure to over 500 million potential customers around the world. Therefore, uploading the content to each and every one of these platforms is a process that has and will keep us busy for the next couple of months. We expect that by December 2021 all of our educational materials will be properly uploaded. Hence, CHNC hopes to bring in additional revenues for 2022 to the tune of $1 million to $1.5 million. We believe that with this level of exposure, combined with the quality of our content and hard work, this strategy will represent a 180 degree turn for the financial journey of CHNC.

We are also glad to announce that it is not only our line of products that is expanding but our ever-growing line of excellent personnel. We have welcomed 6 new associates during this last week and will be looking forward to retaining the services of 6 to 10 more hopefully by the end of the month.  The acquisition of extra partners will enable us to meet our ambitious growth demands and will pave the way for the end of the year goals of launching our sales campaign during the holiday season in order to gain a strong entrance for 2022.

“As our company continues to grow, CHNC has to expand in order to reach new markets, regions and communities, and to match the level of innovation, production and execution that our team delivers day by day,” says Henry Levinski, CHNC’s Treasurer.

To learn more visit:

Safe Harbor Statement

The information posted in this release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by use of the words "may," "will," "should," "plans," "explores," "expects," "anticipates," "continue," "estimate," "projects," "intends," and similar phrases. Forward-looking statements involve risks and uncertainties that could cause actual results to differ from those projected or anticipated. These risks and uncertainties include, but are not limited to, general economic and business conditions, effects of geopolitical conditions, competition, changes in technology and methods of marketing, and various other factors beyond the company's control.

For more information contact us at:



817/528-2475 for English

214/733-0868 for Spanish



EN
18/10/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on China Infrastructure Construct

 PRESS RELEASE

CBIH Evaluates a Potential Reg A Offering of Approximately $1,000,000 ...

Houston, Texas--(Newsfile Corp. - January 21, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today that it is in the evaluation stage of a potential financing transaction under Regulation A (Reg A), in an estimated amount in the order of $1,000,000, subject to change, internal review, and applicable market and compliance conditions.CBIH clarifies that this communication reflects a serious corporate and executive planning approach intended to protect business value and accelerate operati...

 PRESS RELEASE

CBIH Puts CMS at the Center of the Board: Formal Coordination with Dr....

Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, announced today the launch of its Evidence Sprint 2026, an intensive execution phase designed to turn cannabinoid science into usable medical evidence: protocols, operational collaboration, and projects ready for competitive funding.CBIH confirms receipt of a communication from the Centers for Medicare & Medicaid Services (CMS) acknowledging Company's meeting request with CMS Administrator Dr. Mehmet Oz a...

 PRESS RELEASE

CBIH Launches Federal and Pharmaceutical Outreach Initiative to Accele...

Houston, Texas--(Newsfile Corp. - January 5, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced the launch of a national outreach and partnership initiative designed to capitalize on the accelerating federal momentum toward moving cannabis from Schedule I to Schedule III through the ongoing rescheduling rulemaking process. On December 18, 2025, a Presidential Executive Order directed the U.S. Attorney General to take necessary steps to complete the rulemaking process related to resche...

 PRESS RELEASE

CBIH Announces New Patent Initiative Targeting Opioid Addiction Throug...

Houston, Texas--(Newsfile Corp. - December 29, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on the OTC Markets under the ticker symbol CBIH, today announced that it is pursuing a new patent for an investigational therapy designed to address opioid addiction, a condition that continues to claim tens of thousands of lives each year in the United States.According to U.S. public health data, more than 700,000 people have died from opioid-involved overdoses since the early 2000s. Despite recent progress, the crisis remains severe: in 2024 alone, a...

 PRESS RELEASE

CBIH Welcomes Federal Momentum Toward Cannabis Rescheduling as 2026 Op...

Houston, Texas--(Newsfile Corp. - December 22, 2025) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH) (CBIH) announces a landmark corporate and industry moment following recent indications that President Donald Trump will support federal actions that advance the rescheduling of marijuana from Schedule I to Schedule III. The development is widely regarded as one of the most consequential policy shifts in nearly two decades of national debate.After eighteen years of navigating scientific challenges, market volatility, stigma, and regulatory uncertainty, CBIH stated that this turn...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch